Citation Impact
Citing Papers
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 Standout
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
2011
La carga de enfermedad, lesiones, factores de riesgo y desafíos para el sistema de salud en México
2013
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy
2002
Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro
2000
A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
2003
Acute kidney injury
2012 Standout
FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury
2019
Plk3 Functions as an Essential Component of the Hypoxia Regulatory Pathway by Direct Phosphorylation of HIF-1α
2010
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis
2003
Diabetic renal disease: from recent studies to improved clinical practice
2004
Short and long term effects of antihypertensive therapy in the diabetic rat
1989
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Traditional Cardiac Risk Factors in Individuals with Chronic Kidney Disease
2003
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
2011
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
2014
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
The metabolic syndrome
2010 Standout
Role of aldosterone in the remnant kidney model in the rat.
1996
Hallmarks of aging: An expanding universe
2023 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Renal handling of albumin: A critical review of basic concepts and perspective
2002
Management of High Blood Pressure in African Americans<subtitle>Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks</subtitle>
2003
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Differentially expressed miRNAs in circulating exosomes between atrial fibrillation and sinus rhythm
2019
Ischemic renal diseases: New insights into old entities
1998
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
2002
The metabolic syndrome
2005 Standout
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
1994 Standout
Necrotizing Enterocolitis
2011 Standout
Downregulation of theKlothoGene in the Kidney under Sustained Circulatory Stress in Rats
1998
Nephropathy in Patients with Type 2 Diabetes
2002
Impact of renal failure on the risk of myocardial infarction and death
2002
Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001
Angiotensin Converting Enzyme Inhibitors and Progressive Renal Insufficiency
1989
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study
2003
Treatment of Hypertension in Adults With Diabetes
2003
Alzheimer's Disease
2010 Standout
Relationship of renal function to homocysteine and lipoprotein(a) levels: The frequency of the combination of both risk factors in chronic renal impairment
2002
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Cardiovascular disease and chronic renal disease: A new paradigm
2000
The basics of epithelial-mesenchymal transition
2009 Standout
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
2009
Progression of Renal Disease and Renal Hypertrophy
1995
The Hallmarks of Aging
2013 Standout
Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes
2002
The effect of RAAS blockade on the progression of diabetic nephropathy
2013
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Feeding premature infants while low umbilical artery catheters are in place: A prospective, randomized trial
1994
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients
2002
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
1988 Standout
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Homocysteine and Atherothrombosis
1998 Standout
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Blockage of Tubular Epithelial to Myofibroblast Transition by Hepatocyte Growth Factor Prevents Renal Interstitial Fibrosis
2002
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Treatment of Cardiovascular and Renal Risk Factors in the Diabetic Hypertensive
2002
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
1997 Standout
Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
1992
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Angiotensin-Converting Enzyme Inhibition and Renal Protection
1993
Nifedipine Prevents Renal Injury in Rats With Chronic Nitric Oxide Inhibition
1995
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
1985 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Biophysical properties of normal and diseased renal glomeruli
2010
Cyclosporine nephrotoxicity
1986
Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats
1998
Renal Dysfunction Complicating the Treatment of Hypertension
2002
Why the kidney glomerulus does not clog: A gel permeation/diffusion hypothesis of renal function
2003 StandoutNobel
Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis
2003
The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease
2004
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003
Homocysteine and Cardiovascular Disease
1998 Standout
Effectiveness of Management Strategies for Renal Artery Stenosis: A Systematic Review
2006
Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis
2003
Nephron adaptation to renal injury or ablation
1985
Cystatin C-Properties and use as diagnostic marker
2001
Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism.
1998
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.
1997 Standout
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
2002
Elevated blood pressures in mice lacking endothelial nitric oxide synthase
1996 StandoutNobel
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy
2002
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Works of Lance D. Dworkin being referenced
Hepatocyte Growth Factor Protects Renal Epithelial Cells from Apoptotic Cell Death
1998
Up-regulation of hepatocyte growth factor receptor: An amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure
1999
MicroRNA profiling in kidney disease: Plasma versus plasma-derived exosomes
2017
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001
Glomerular size-selective barrier dysfunction in nephrotoxic serum nephritis
1988
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trial
2006
Serum Cystatin C as a Determinant of Fasting Total Homocysteine Levels in Renal Transplant Recipients with a Normal Serum Creatinine
1999
Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys
1992
Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms
1993
Activation of PI3K–Akt–GSK3β pathway mediates hepatocyte growth factor inhibition of RANTES expression in renal tubular epithelial cells
2005
Efficacy and Safety of Renal Tubule Cell Therapy for Acute Renal Failure
2008
Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR
1991
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways
2000
Renal vascular effects of antihypertensive therapy in uninephrectomized SHR
1989
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.
1984
Preserving renal function in adults with hypertension and diabetes: A consensus approach
2000
Small Intestinal Mass of the Rat is Partially Determined by Indirect Effects of Intraluminal Nutrition
1976
Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis Patients
1997
Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension.
1986
Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression
2015
Does essential hypertension cause end-stage renal disease?
1992
Glomerular hypertension and injury in desoxycorticosterone–salt rats on antihypertensive therapy
1987
Effects of nifedipine and enalapril on glomerular injury in rats with deoxycorticosterone-salt hypertension
1990